242 related articles for article (PubMed ID: 10422958)
1. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.
Atz AM; Wessel DL
Anesthesiology; 1999 Jul; 91(1):307-10. PubMed ID: 10422958
[No Abstract] [Full Text] [Related]
2. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease.
Ivy DD; Kinsella JP; Ziegler JW; Abman SH
J Thorac Cardiovasc Surg; 1998 Apr; 115(4):875-82. PubMed ID: 9576224
[TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP phosphodiesterase-5: target of sildenafil.
Corbin JD; Francis SH
J Biol Chem; 1999 May; 274(20):13729-32. PubMed ID: 10318772
[No Abstract] [Full Text] [Related]
4. Cardiovascular data on sildenafil citrate: introduction.
Zusman RM
Am J Cardiol; 1999 Mar; 83(5A):1C-2C. PubMed ID: 10078536
[No Abstract] [Full Text] [Related]
5. Sildenafil (Viagra) and ophthalmology.
Marmor MF
Arch Ophthalmol; 1999 Apr; 117(4):518-9. PubMed ID: 10206581
[No Abstract] [Full Text] [Related]
6. Sildenafil can increase the response to inhaled nitric oxide.
Bigatello LM; Hess D; Dennehy KC; Medoff BD; Hurford WE
Anesthesiology; 2000 Jun; 92(6):1827-9. PubMed ID: 10839936
[No Abstract] [Full Text] [Related]
7. Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
Lewis GD; Semigran MJ
Curr Heart Fail Rep; 2004 Dec; 1(4):183-9. PubMed ID: 16036043
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil (viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device.
Mychaskiw G; Sachdev V; Heath BJ
J Clin Anesth; 2001 May; 13(3):218-20. PubMed ID: 11377161
[TBL] [Abstract][Full Text] [Related]
9. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage.
Rodríguez-Iturbe B; Ferrebuz A; Vanegas V; Quiroz Y; Espinoza F; Pons H; Vaziri ND
Kidney Int; 2005 Nov; 68(5):2131-42. PubMed ID: 16221212
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil.
Gibson A
Eur J Pharmacol; 2001 Jan; 411(1-2):1-10. PubMed ID: 11137852
[TBL] [Abstract][Full Text] [Related]
11. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.
Patil CS; Singh VP; Kulkarni SK
Inflammopharmacology; 2005; 13(5-6):467-78. PubMed ID: 16280099
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
[TBL] [Abstract][Full Text] [Related]
13. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
Lee JE; Hillier SC; Knoderer CA
J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 5A as a target in cardiac disease.
Doggrell SA
Expert Opin Ther Targets; 2005 Oct; 9(5):1097-100. PubMed ID: 16185160
[No Abstract] [Full Text] [Related]
16. Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation?
Méhats C; Schmitz T; Breuiller-Fouché M; Leroy MJ; Cabrol D
Am J Obstet Gynecol; 2006 Jul; 195(1):184-5. PubMed ID: 16813753
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil for enhanced performance at high altitude?
Rubin LJ; Naeije R
Ann Intern Med; 2004 Aug; 141(3):233-5. PubMed ID: 15289224
[No Abstract] [Full Text] [Related]
18. KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5.
Hirose R; Okumura H; Yoshimatsu A; Irie J; Onoda Y; Nomoto Y; Takai H; Ohno T; Ichimura M
Eur J Pharmacol; 2001 Nov; 431(1):17-24. PubMed ID: 11716838
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil citrate therapy for pulmonary arterial hypertension.
Hoeper MM; Welte T
N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16525151
[No Abstract] [Full Text] [Related]
20. Sildenafil citrate therapy for pulmonary arterial hypertension.
Izbicki G; Rosengarten D; Picard E
N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16528809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
